Former Nebraska Sen. Ben Sasse, less than four months after revealing a Stage 4 pancreatic cancer diagnosis, sat down with The New York Times columnist Ross Douthat and described in blunt, unflinching terms what it feels like to be told you have months to live, and why he refuses to make peace with dying.
The conversation, released Thursday on Douthat's "Interesting Times" podcast, marked Sasse's most detailed public account of his condition. He told Douthat he received a three- to four-month life expectancy in mid-December and was subsequently informed he had five distinct forms of cancer: lymphoma, vascular cancer, lung cancer, liver cancer, and pancreatic cancer, where the disease originated.
The Hill reported that Sasse, now roughly 99 days past that grim prognosis, said he is doing far better than he was at Christmas. His pain, he said, has been reduced by 80 percent since his initial diagnosis, though he still deals with nausea and facial bleeding from daraxonrasib, a drug in his treatment regimen.
For a man who spent eight years in the U.S. Senate, led Midland University in Fremont, Nebraska, and then served as president of the University of Florida, the interview was not a policy discussion. It was something rarer in public life, a father of three talking openly about the prospect of leaving his children behind.
Sasse described the emotional weight of his diagnosis with a word he kept returning to: "heaviness." He spoke about his 14-year-old son and his two daughters, ages 22 and 24, and what it means to face the possibility that he won't be there for them.
"I didn't like the idea of my 14-year-old son not having a dad around at 16. I didn't like the idea of my daughters, who are 22 and 24, not having their dad there to walk them down the aisle. I felt a real heaviness about that."
That heaviness, Sasse told Douthat, has not broken him. He said he has "continued to feel a peace about the fact that death is something that we should hate."
The line is worth pausing on. In an era when public figures often reach for therapeutic platitudes about "journeys" and "acceptance," Sasse went the other direction. He called death a "wicked thief", and then, in the same breath, expressed a distinctly Christian hope about what lies on the other side.
"And yet, it's pretty good that you pass through the veil of tears one time and then there will be no more tears, there will be no more cancer."
When Sasse first disclosed his diagnosis publicly, he was equally direct. In his initial announcement, he wrote plainly: "Last week I was diagnosed with metastasized, stage-four pancreatic cancer, and am gonna die." He called advanced pancreatic cancer "nasty stuff" and "a death sentence," while also saying his Christian faith shapes how he understands suffering, death, and hope.
The scope of Sasse's illness is staggering. Over the course of a few days following his mid-December consultation, doctors told him the pancreatic cancer had already spawned four additional malignancies. He laid out the list for Douthat without flinching.
"They told me over the course of the next couple of days that I already have five forms of cancer: lymphoma, vascular, lung cancer, bad liver cancer and pancreatic, where it originated. So, it was pretty clear that we're dealing with a short number of months left to live."
Sasse praised his medical team at MD Anderson Cancer Center in Houston, naming oncologists Dr. Shubham Pant and Dr. Bob Wolff as his primary physicians. He also spoke warmly of his hospice doctor, though he did not name that individual. His description of the researchers working on pancreatic cancer was vivid and sobering.
"They describe their work as being up here with a little pickax on a giant Hoover Dam working on pancreatic cancer. They get little cracks at the top and sometimes little bits of water splash over and there's somebody else doing it 400 meters over."
The metaphor captures the grim reality of pancreatic cancer treatment. Researchers chip away at a massive problem in isolation, making incremental progress that rarely converges into a breakthrough. Sasse, who holds a Yale Ph.D. and spent his career in policy and higher education, understood the implications of that image without needing them spelled out.
Fox News reported that Sasse has multiple tumors growing in and around his spinal column, which caused severe pain early in the diagnosis. He and his wife Melissa understood from the beginning, he said, that "the probability of a relatively near-term death is pretty high."
Sasse's path to this moment has been marked by service and sacrifice. He ran Midland University in Fremont, Nebraska, before winning his Senate seat. He represented Nebraska for eight years, building a reputation as a principled conservative willing to buck party leadership when he believed the moment required it.
He resigned from the Senate to become president of the University of Florida, a move that placed him at the helm of one of the nation's flagship public universities. But that chapter was short-lived. In July 2024, Sasse stepped down from Florida, citing his wife Melissa's recent epilepsy diagnosis. The decision drew relatively little national attention at the time. In hindsight, it was the first sign that the Sasse family was entering a period of profound medical crisis.
Sasse is not the only prominent figure in public life to face a serious health diagnosis in recent months. White House Chief of Staff Susie Wiles disclosed a breast cancer diagnosis earlier this year, vowing to continue in her role while undergoing treatment. These disclosures remind the public that the people who serve in government are not abstractions, they are human beings with families, fears, and finite time.
The Associated Press noted that Sasse wrote on social media at the time of his diagnosis: "I'm not going down without a fight." That defiance has carried through into his treatment. He told Douthat that despite the nausea and bleeding side effects from daraxonrasib, his pain is dramatically reduced, an 80 percent improvement from where he started.
National Review reported that Sasse served in the Senate from 2015 to 2023 and later resigned as University of Florida president in 2024 to care for his wife, adding that he described his diagnosis as terminal while also making clear he intended to pursue every available treatment.
What distinguishes Sasse's public reckoning from many others is the specificity of his faith. He is not offering vague spiritual comfort. He is making a theological argument: death is real, death is an enemy, and the proper response is to hate it, while also trusting that it does not get the last word.
That framework matters. In a culture that increasingly treats death as either a clinical event to be managed or a taboo to be avoided, Sasse is doing something countercultural. He is naming death as evil, refusing to dress it up, and simultaneously expressing confidence that something better waits beyond it.
Cancer has a way of stripping away pretense. The policy fights, the committee hearings, the university budget battles, all of it recedes when a doctor tells you the timeline. Efforts to expand cancer screening continue at the state level, but for patients like Sasse, the fight is already personal and immediate.
Sasse said his diagnosis reshaped what mattered to him. The things that once consumed his attention, the daily grind of politics, institutional management, public reputation, fell away. What remained was family and faith.
There is a lesson in that clarity, even for those of us not facing a terminal diagnosis. Public life rewards ambition, positioning, and performance. When serious illness enters the picture, the hierarchy of what matters rearranges itself in an instant.
Sasse told Douthat he is at roughly Day 99 since receiving his life expectancy. He was given three to four months. By simple math, he is approaching the outer edge of that window, and he is still here, still talking, still fighting.
"In mid-December I got a three- to four-month life expectancy, and I'm at Day 99 or something since then, and I'm doing a heck of a lot better than I was doing at Christmas."
The medical team at MD Anderson continues its work. The daraxonrasib continues its side effects. And Sasse continues to show up, for his family, for his faith, and now, for a public conversation about what it means to face the end with honesty.
Open questions remain. The exact timeline of his diagnosis, the full details of his treatment protocol, and the long-term prognosis beyond the initial window are all unclear. Serious illness reshapes public careers in ways that are impossible to predict, and Sasse's story is still being written.
But what Sasse has already given the public, a clear-eyed, faith-grounded account of terminal illness from a man who refuses to pretend it's anything other than terrible, is worth more than most of what passes for courage in Washington.
A man who calls death a wicked thief and still expects to see the other side of it is not performing bravery. He is living it.